Clinical Trials Browser

Phase 1/2 × Leukemia, Myeloid × blinatumomab × Clear all

NCT07604233 2026-05-22

Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AML

Phase 1/2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Myeloid